⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12199389 | 1.00 | — | — | |
| SCHEMBL463628 | 0.75 | — | — | |
| SCHEMBL3045849 | 0.72 | — | — | |
| SCHEMBL13813580 | 0.71 | — | — | |
| SCHEMBL893513 | 0.71 | — | — | |
| SCHEMBL6552477 | 0.69 | — | — | |
| SCHEMBL26810 | 0.63 | — | — | |
| SCHEMBL13937029 | 0.62 | — | — | |
| SCHEMBL471283 | 0.62 | — | — | |
| Fluoride SCHEMBL8981505 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673855-B2 | Voltage gated sodium channel imaging agents | THE GENERAL HOSPITAL CORPORATION (US) | 2023-06-13 | — | — | US | disclosed |
| US-11117858-B2 | Voltage gated sodium channel imaging agents | THE GENERAL HOSPITAL CORPORATION (US) | 2021-09-14 | — | — | US | disclosed |
| EP-2768307-B1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS INC (US) | 2020-03-18 | — | — | EP | disclosed |
| US-20200031762-A1 | VOLTAGE GATED SODIUM CHANNEL IMAGING AGENTS | THE GENERAL HOSPITAL CORPORATION | 2020-01-30 | — | — | US | disclosed |
| EP-2550002-B1 | RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS | PHIO PHARM CORP (US) | 2019-05-08 | — | — | EP | disclosed |
| US-20180022719-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | PIRAMAL IMAGING SA (CH) | 2018-01-25 | — | — | US | disclosed |
| US-20170309487-A1 | STRUCTURES AND METHODS FOR EQUIVALENT OXIDE THICKNESS SCALING ON SILICON GERMANIUM CHANNEL OR III-V CHANNEL OF SEMICONDUCTOR DEVICE | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-10-26 | — | — | US | disclosed |
| US-20170309723-A1 | STRUCTURES AND METHODS FOR EQUIVALENT OXIDE THICKNESS SCALING ON SILICON GERMANIUM CHANNEL OR III-V CHANNEL OF SEMICONDUCTOR DEVICE | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-10-26 | — | — | US | disclosed |
| US-9682944-B2 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors | PIRAMAL IMAGING SA (CH) | 2017-06-20 | — | — | US | disclosed |
| US-9682944-B2 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors | PIRAMAL IMAGING SA (CH) | 2017-06-20 | — | — | US | disclosed |
| US-20100233086-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20090274985-A1 | POWDERED FUEL CONVERSION SYSTEMS AND METHODS | MCKNIGHT JAMES K | 2009-11-05 | — | — | US | disclosed |
| US-20090191129-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | Lantheus Biosciences Ltd. (GB) | 2009-07-30 | — | — | US | disclosed |
| EP-1802621-B1 | CRF RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO | SMITHKLINE BEECHAM CORK LTD (IE) | 2009-05-06 | — | — | EP | disclosed |
| EP-1519297-B1 | An IC card processor | HITACHI OMRON TERMINAL SOLUTIONS CORP (JP) | 2009-02-11 | — | — | EP | disclosed |
| WO-2008124703-A2 | DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008028533-A1 | PHENYLOXYANILINE DERIVATIVES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |
| US-20080004218-A1 | METHODS FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES FOR TREATING AND PREVENTING OBESITY | NASTECH PHARMACEUTICAL COMPANY INC. | 2008-01-03 | — | — | US | disclosed |
| US-20070197437-A1 | COMPOSITIONS FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES | NASTECH PHARMACEUTICAL COMPANY INC. | 2007-08-23 | — | — | US | disclosed |
| US-20070161563-A1 | A DEVICE FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES | NASTECH PHARMACEUTICAL COMPANY INC. | 2007-07-12 | — | — | US | disclosed |